Clinical Trials Browser

INDUSTRY × IMC-001 × 90 days × Clear all

NCT04414163 2026-04-24

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

Phase 2 Active not recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06365840 2026-04-17

TMB-H

Phase 2 Recruiting

Other solid neoplasm

TMB-H